article thumbnail

Optum: Why COVID-19 could significantly change the drug development pipeline

FierceHealthIT

Optum: Why COVID-19 could significantly change the drug development pipeline. Fri, 12/11/2020 - 12:12.

article thumbnail

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

Digital Health Global

Under the program, Deliberate AI’s assessment tool for anxiety and depression, the AI-generated Clinical Outcome Assessment or AI-COA , will receive support to become a qualified drug development tool (DDT). Global experts have also expressed support for Deliberate AI’s innovative approach.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025.

article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. Background to the Teladoc Livongo merger The Teladoc Livongo merger was announced on August 5, 2020. The deal was completed on October 30, 2020. October 30, 2020: The merger is completed.

article thumbnail

Asaya and medical cannabis care in the era of personalised medicine

Lloyd Price

A new medication is introduced to the market via legislation rather than through formal drug development practices (3); 3. We see a reversal of the trend towards single molecule drug development in favour of the use of raw botanical products containing complex chemovars. PNAS Nov 2020; vol. References. 1 Dolgin E.

article thumbnail

Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more

Healthcare IT Today

Cybersecurity company Surfshark found the number of government requests for user data increased 4x from 2013 to 2020 among Apple, Google, Facebook, and Microsoft. While 7 out of 10,000 may not seem like a lot, a large hospital with up to 20 connected devices per patient room could have several devices at risk.

eCare 75
article thumbnail

Metformin Myths and Misconceptions

DrKumo Remote Patient Monitoring

Though the drug metformin (a biguanide formed by the fusion of two guanidines) was developed in 1922 by Wermer and Bell, it was the efforts of the French physician Jean Sterne that paved the way for the use of metformin as a glucose-lowering drug. Updated 2020 Jan 21]. Griffin, S.J., Leaver, J.K. & & Irving, G.J.